Comparative study of molecular docking, structural, electronic, and fukui function studies on favipiravir and its newly designed derivatives (potential inhibitors) for COVID-19 protease

Simple item page
dc.contributor.authorPandey, Anoop Kumar
dc.contributor.authorSingh, Vijay
dc.contributor.authorDwivedi, Apoorva
dc.date.accessioned2024-03-27T12:49:00Z
dc.date.available2024-03-27T12:49:00Z
dc.date.issued2023
dc.descriptionAbstract. Full Text Article is available at https://doi.org/10.1002/masy.202200028en_US
dc.description.abstractFavipiravir is an comparative molecular docking currently being trialed as a COVID-19 treatment. These results motivate us to develop new species (possibly drugs) from favipiravir, perform comparative molecular docking, and re-examine their biological and pharmacological activities. Detailed quantum chemical research on favipiravir and its newly designed derivatives has been carried out with the help of DFT/B3LYP/6–311 + + G (d, p). In the present work, the structure of favipiravir has been modified and 12 new species have been modeled (all species are inherently stable because no virtual frequency is found during the vibration analysis). Reactivity of all species using various descriptors (local) such as Fukui function, local softness, electrophilicity, and global, i.e., electronegativity, hardness, HOMO–LUMO gap, etc. of the same are calculated and discussed. In silico studies such as molecular docking of all species and complete quantum chemistry studies suggest that four of them may mitigate the effects of the COVID-19 protease.en_US
dc.identifier.citationPandey, A. K., Singh, V., & Dwivedi, A. (2023). Comparative study of molecular docking, Structural, Electronic and Fukui Function Studies on Favipiravir and its newly designed derivatives (Potential Inhibitors) for COVID‐19 Protease. In Macromolecular Symposia, 407 (1) .en_US
dc.identifier.otherDOI: https://doi.org/10.1002/masy.202200028
dc.identifier.urihttps://repository.udom.ac.tz/handle/20.500.12661/4444
dc.language.isoenen_US
dc.publisherWiley Online Libraryen_US
dc.subjectMolecular dockingen_US
dc.subjectCOVID-19 Proteaseen_US
dc.subjectPotential Inhibitorsen_US
dc.subjectFavipiraviren_US
dc.subjectComparative molecular dockingen_US
dc.subjectFukui function studiesen_US
dc.subjectCOVID-19 treatmenten_US
dc.subjectAntiviral medicationen_US
dc.titleComparative study of molecular docking, structural, electronic, and fukui function studies on favipiravir and its newly designed derivatives (potential inhibitors) for COVID-19 proteaseen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
pandey.pdf
Size:
79.83 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Journal Articles